September 30, 2021 | CRISPR, Impetus Digital, Jessica Schwaber, Natalie Yeadon, Solupore, allogeneic therapies, cell engineering, cell therapy, gene therapy, gene-editing, non-viral modalities, precision medicine, viral modalities
Jessica Schwaber, Scientific Director, Cell & Gene Therapy, Avectas, explores her company’s unique cell engineering platform, the recent shift in cell & gene therapy commercial needs, current barriers to realizing the full potential of cell & gene therapy, and much more.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches…
Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.
Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives…
Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional…
We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.
Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.
While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear…
Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and…
Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with…
Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting…
